Obinutuzumab as consolidation after chemo-immunotherapy is highly effective in achieving MRD clearance from bone marrow and peripheral blood-Initial results of UK NCRI Phase II/III GALACTIC trial

Munir, T, Howard, D orcid.org/0000-0003-3333-9783, McParland, L et al. (10 more authors) (2018) Obinutuzumab as consolidation after chemo-immunotherapy is highly effective in achieving MRD clearance from bone marrow and peripheral blood-Initial results of UK NCRI Phase II/III GALACTIC trial. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley, p. 79. ISSN: 0007-1048 EISSN: 1365-2141

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Keywords: MRD
Dates:
  • Published (online): 16 April 2018
  • Published: 16 April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK
C18027/A13762
Roche Products Ltd
MAWE1415R61
Depositing User: Symplectic Publications
Date Deposited: 15 May 2018 09:48
Last Modified: 15 May 2018 09:48
Status: Published
Publisher: Wiley
Identification Number: 10.1111/bjh.15226
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics


CORE (COnnecting REpositories)